In patients who have received less than 14 days of dexamethasone therapy, treatment may be abruptly discontinued without adverse events, because the HPA axis is not suppressed (Kountz & Clark ...

Dexamethasone's side effects include anxiety ... The BBC's Rebecca Morelle explains how the monoclonal antibodies work Regeneron's treatment was developed using cells derived from an aborted ...

In the setting of this urgency, drug repurposing emerged as a powerful strategy for identifying potential treatments -- utilizing medications already available on pharmacy shelves around the world.

New Darzelex SC quadruplet regimen approved by European Commission for newly diagnosed multiple myeloma patients.

Myeloma UK joined with patients and clinicians to challenge the decision, and today NICE confirmed that Elrexfio will now be ...

Binod Dhakal, MD, MS, discusses how the efficacy results observed with ciltacabtagene autoleucel in the CARTITUDE-4 trial compare with other therapies that are used for the treatment of ...

Sarclisa in combination with the VRd regiment was superior to VRd alone in improving survival in stem cell transplant ...

Plitidepsin (Aplidin®) demonstrates promise as a candidate therapy in the management of moderate COVID-19 in hospitalized adults requiring oxygen supplementation.

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...

It can be used together with bortezomib and dexamethasone for patients who have already received at least one line of treatment or with dexamethasone in those who have already received four lines ...

About the Phase 3 DIAMOND Program of OCS-01 in Diabetic Macular Edema ...